Skip to main content
Equibles
PRGO logo

PRGO · PERRIGO Co plc · Metrics

Track PRGO — free

Use PRGO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRGO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$13.48 -0.06 (-0.44%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.88B
Shares
138.77M

PRGO metrics

79 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$13.54
Market cap
$1.88B

Price action

20 metrics
Price change (1W)
-5.6%
Price change (30D)
+4.4%
Price change (3M)
+33.3%
Price change (6M)
+36.2%
Price change (YTD)
-2.7%
Price change (1Y)
-36.6%
Trailing year
Price change (5Y)
-69.4%
52-week high
$22.51
52-week low
$9.25
Change from 52-week high
-39.8%
Change from 52-week low
+46.4%
Annualized volatility
54.9%
Annualized volatility (3M)
66.7%
Beta
1.1
RSI (14D)
49.7
Price vs SMA 50
+9.2%
Price vs SMA 200
+10.7%
Avg volume (3M)
3.20M
Relative volume
0.7
Average dollar volume
$37.29M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
138.77M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.2×
reciprocal yield 86.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 220.9%
P / book
0.7
reciprocal yield 134.1%
FCF yield
6.4%
TTM · current market cap
Buyback yield
15.6%
P / FCF
15.7
reciprocal yield 6.4%
P / operating cash flow
9.6
reciprocal yield 10.5%
Earnings yield
-92.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.5×
reciprocal yield 67.1%
EV / revenue historical average (5Y)
1.6×
reciprocal yield 62.2%
EV / EBIT historical average (3Y)
63.7×
reciprocal yield 1.6%
EV / EBIT historical average (5Y)
56.9×
reciprocal yield 1.8%
EV / EBITDA historical average (3Y)
16.4×
reciprocal yield 6.1%
EV / EBITDA historical average (5Y)
16.8×
reciprocal yield 6.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
33.3%
Operating margin
-37.7%
Trailing 12 months
Net margin
-41.9%
Gross profit (TTM)
$1.38B
Operating profit (TTM)
−$1.56B
Net income (TTM)
−$1.73B
Trailing 12 months
Diluted EPS (TTM)
$-12.52
FCF margin
2.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$21.33

Growth

11 metrics
Revenue growth YoY
-3.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$4.14B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.0%
Year over year · more shares
Revenue CAGR (3Y)
-1.5%
Revenue CAGR (5Y)
+0.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-11.7%
FCF CAGR (5Y)
-20.8%

Quality

14 metrics
Return on equity
-69.0%
Return on assets
-22.8%
Debt / equity
1.3
Current ratio
2.3
EBITDA (TTM)
−$1.21B
Free cash flow (TTM)
$119.30M
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$2.90B
Latest balance sheet
Cash & equivalents
$399.70M
Total assets
$7.61B
Total debt
$3.29B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$196.10M
Capital expenditures (TTM)
$76.80M
R&D (TTM)
$95.00M
SG&A (TTM)
—
Stock compensation (TTM)
$47.40M
R&D / revenue
2.3%
Stock compensation / revenue
1.1%

Ownership (13F)

3 metrics
13F filers
341
13F filer change QoQ
+11
Institutional ownership
117.6%

Short interest

3 metrics
Short interest
16.3%
Latest settlement · 9.0 days to cover
Days to cover
9.0d
Short-squeeze score
87 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1585364 CUSIP G97822103 13F (30d) 11 filings 11 filers Visit website Investor relations